Touchlight’s dbDNA™ manufacturing facility receives world-first GMP license from MHRA Published: 14 January 2025 Touchlight’s dbDNA technology is the first synthetic DNA technology to receive a GMP certificate globally Touchlight…
Read More
As advanced therapies continue to transform the healthcare landscape, the need for sustainable manufacturing solutions grows more critical. Traditional plasmid DNA (pDNA) production presents costly, resource-intensive challenges, threatening scalability and…
Read More
Rewriting the Rules of Gene Therapy with Nonviral DNA Delivery Published: 14 November 2024 Lisa Caproni, Ph.D. As gene therapy continues to evolve, nonviral DNA delivery is rapidly gaining traction…
Read More
ELENA STOYANOVA, PH.D. & TOM ADIE, PH.D. Touchlight is at the forefront of innovation in gene editing technology with our groundbreaking MegaBulb DNA (mbDNA). This novel, circular, single-stranded DNA template…
Read More
Touchlight to supply GMP dbDNA to support University of Nottingham’s clinical study for a next-generation vaccine for Zika virus Published: 21 August 2024 Touchlight, an innovation-driven contract development and manufacturing…
Read More
Touchlight and GSK sign license agreement for use of enzymatic dbDNA production technology for mRNA manufacturing Published: 23 July 2024 Agreement enables GSK access to enzymatic production technology for rapid…
Read More
Touchlight is pioneering the next generation of DNA manufacturing with our transformative dbDNA™ technology. The enzymatic DNA manufacturing platform sets new industry standards for speed, purity, and scalability, overcoming the…
Read More
Touchlight and LenioBio collaborate to accelerate development of protein therapeutics for pandemic response Published: 2 July 2024 Touchlight to participate in LenioBio’s recently announced grant from CEPI 02 July, HAMPTON,…
Read More
TOM MERRITT, PH.D. Traditional methods for the production of adeno-associated viral (AAV) vectors — crucial components in gene therapies — rely on plasmid DNA (pDNA), which can pose safety concerns…
Read More
Touchlight Genetics and the National Physical Laboratory (NPL) awarded grant to develop novel gene-length single-stranded genome editing template. Published: 9 May 2024 Touchlight Genetics, in partnership with the National Physical…
Read More
